Gujarat Themis Biosyn Share price

Q: How to buy Gujarat Themis Biosyn Share at Choice?

To buy Gujarat Themis Biosyn stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Themis Biosyn, choose your preferred order type, and place the trade.

GUJTHEM

Healthcare Mid Cap

370.4

1.65 (-0.44%)

NSE

BSE

Last updated on 16 Jul, 2026 | 15:31 IST

BUYSELL

Today's High

377.35

Today's Low

366.05

52 Week Low

225.05

52 Week High

479.00

Gujarat Themis Biosyn share price chart

ChartIQ

TradingView

Gujarat Themis Biosyn Share Key Metrics

Volume

56597.00

Market Cap

4036.07 CR

LTQ@LTP

10@370.40

ATP

369.82 Var Margin

25.87 %

Circuit Range

297.65-446.45

Delivery %

46.14 %

Value

2.09 CR

ASM/GSM

No

Market Lot

1

Summary

GUJTHEM stock price is ₹370.4 as of 17 Jul, 2026. The stock intraday movement has stayed between ₹366.05 and ₹377.35, while Gujarat Themis Biosyn share price 52 week high low is ₹225.05 & ₹479.00.

In terms of trading activity, GUJTHEM share price has recorded a volume of 56,597 shares. The Gujarat Themis Biosyn has a market cap of ₹108965265. The stock’s Average Traded Price (ATP) stands at ₹369.82, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹370.40.

The Gujarat Themis Biosyn upper circuit limit is ₹446.45 & The Gujarat Themis Biosyn lower circuit limit is ₹297.65, with a Value of ₹2.09 CR. The Delivery Percentage for the day is 46.14%.

Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.

Gujarat Themis Biosyn Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

70.14

Sector P/B

3.3

Sec. Div. Yield

0.52

Gujarat Themis Biosyn Resistance and Support

Pivot 372.32

Resistance

First Resistance

380.74

Second Resistance

389.42

Third Resistance

397.84

Support

First Support

363.64

Second Support

355.22

Third Support

346.54

Gujarat Themis Biosyn Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.86%

Mutual Fund

1.16%

Insurance

0%

Foreign Institutional Investors

1.8%

Domestic Institutional Investors

0.02%

Retail

26.16%

Others

0%

Total Promoters

MAR '26

70.86%

Gujarat Themis Biosyn Corporate Actions

Date	Agenda
2026-06-19	To consider Fund Raising
2026-06-06	Fund Raising & Others
2026-05-25	Audited Results
2026-02-05	Quarterly Results
2025-11-10	Quarterly Results
2025-08-01	Quarterly Results
2025-05-20	Audited Results & Final Dividend
2025-02-14	Quarterly Results

Gujarat Themis Biosyn News

Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Regulation 30 (LODR) - Updates On Arbitration Matter.

Gujarat Themis Biosyn has amicably resolved a commercial dispute with Optimus Drugs Private Limited, which was previously subject to arbitration. The settlement results in no penalty for the company and no material financial impact, removing a potential contingent liability.

Jul 13 2026 20:57:46

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Gujarat Themis Biosyn shareholders approved a Special Resolution to raise funds through Qualified Institutions Placement. The resolution passed with an overwhelming 99.9762% of valid votes in favor.

Jul 10 2026 16:55:39

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Gujarat Themis Biosyn shareholders approved a Special Resolution to raise funds through Qualified Institutions Placement (QIP). The resolution passed with 99.97% of votes in favour during the e-voting period which closed on July 8, 2026.

Jul 10 2026 16:51:50

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Gujarat Themis Biosyn shareholders have approved a special resolution to raise funds through Qualified Institutions Placement (QIP) via postal ballot. The resolution passed with 99.9762% of valid votes cast in favour, indicating strong investor support for capital augmentation.

Jul 10 2026 14:54:03

Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Gujarat Themis Biosyn's promoter group, Pharmaceutical Business Group (India) Ltd (PBGIL), has indirectly encumbered 47.02% of its shares. This encumbrance involves 5.12 crore equity shares and is due to a debenture trust deed.

Jul 04 2026 11:22:04

Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

Gujarat Themis Biosyn's promoter, Sachin D. Patel, is set to acquire up to 5.25 lakh equity shares, or 0.48% of the company, from another promoter group entity, Pharmaceutical Business Group (India) Limited. This inter-se transfer is valued up to Rs.20 crore and will increase Sachin D. Patel's holding from 2.29% to 2.77%.

Jul 02 2026 09:39:23

Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Gujarat Themis Biosyn's promoter group, Vividhmargi Investments Private Limited (VIPL), has indirectly encumbered 47.02% of the company's equity. This results from a pledge and non-disposal undertaking created by VIPL over its shares in Pharmaceutical Business Group (India) Limited (PBGIL), which holds a significant stake in Gujarat Themis Biosyn.

Jul 02 2026 08:17:02

Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

Promoter Sachin D. Patel acquired 2.29% equity shares of Gujarat Themis Biosyn from another promoter group entity, Themis Medicare Ltd, via an inter-se transfer at Rs.400.45 per share. This transaction represents a re-arrangement within the promoter group.

Jul 01 2026 11:47:09

Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Gujarat Themis Biosyn's promoter Sachin D. Patel increased his individual shareholding by acquiring 24.97 lakh shares, which is 2.29% of the total voting capital. This change resulted from an inter-se transfer within the promoter group.

Jul 01 2026 11:45:35

Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Regulation 30 (LODR)-Updates

Gujarat Themis Biosyn initiated arbitration proceedings against Optimus Drugs Private Limited. The company is claiming Rs. 900 crore for breach of a supply agreement, covering break fees, financial losses, and delayed payment interest.

Jun 26 2026 19:47:56

Name	Position
Vineet G Gawankar	Company Secretary & Compliance Officer
Dinesh S Patel	Chairman

Gujarat Themis Biosyn Similar Stocks

Aarti Drugs Ltd.

419.90

-1.70 (0.40%)

Advanced Enzyme Technologies Ltd.

325.05

-2.50 (0.76%)

Morepen Laboratories Ltd.

60.83

-0.41 (0.67%)

Panacea Biotec Ltd.

563.95

25.65 (4.77%)

Dishman Carbogen Amcis Ltd.

194.11

1.04 (0.54%)

Hikal Ltd.

234.40

-6.40 (2.66%)

Solara Active Pharma Sciences Ltd.

578.05

0.45 (0.08%)

Kwality Pharmaceuticals Ltd.

2816.90

110.40 (4.08%)

Gujarat Themis Biosyn FAQs

The Buying Price of Gujarat Themis Biosyn share is 370.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Gujarat Themis Biosyn stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Themis Biosyn, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Gujarat Themis Biosyn shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Gujarat Themis Biosyn shares is 0. Useful to assess the stock's value relative to its book value.

To assess Gujarat Themis Biosyn’s valuation compare Sector P/E, P/B which are 70.14 & 3.3 with sector averages, along with growth rates and financial metrics.

The Market Cap of Gujarat Themis Biosyn is 4036.07 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Gujarat Themis Biosyn share price is 479.00 & 225.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Gujarat Themis Biosyn belongs to the Healthcare sector.